The novel mouse mutant, chuzhoi, has disruption of Ptk7 protein and exhibits defects in neural tube, heart and lung development and abnormal planar cell polarity in the ear
1 MRC Harwell, Mammalian Genetics Unit, Harwell, OXON OX11 0RD, UK
2 Centre for Regenerative Medicine, Chancellor's Building, 49 Little France Crescent, Edinburgh, EH16 4SB, UK
3 MRC Centre for Developmental Biology, New Hunts House, Kings College, London SE1 1UL, UK
4 Operations Manager, Research Complex at Harwell, c/o Diamond Light Source Ltd, Diamond House, Harwell Science and Innovation Campus, Oxfordshire, OX11 0DE, UK
5 MRC Harwell, Mary Lyon Centre, Harwell, OXON OX11 0RD, UK
6 Department of Cell Biology, University of Virginia Health System, Charlottesville, VA 22908, USA
7 Institute of Human Genetics, Newcastle University, Newcastle upon Tyne, NE1 3BZ, UK
8 Centre for Biomedical Sciences, School of Biological Sciences, Royal Holloway University of London, Egham, Surrey, TW20 0EX, UK
BMC Developmental Biology 2010, 10:87 doi:10.1186/1471-213X-10-87Published: 12 August 2010
The planar cell polarity (PCP) signalling pathway is fundamental to a number of key developmental events, including initiation of neural tube closure. Disruption of the PCP pathway causes the severe neural tube defect of craniorachischisis, in which almost the entire brain and spinal cord fails to close. Identification of mouse mutants with craniorachischisis has proven a powerful way of identifying molecules that are components or regulators of the PCP pathway. In addition, identification of an allelic series of mutants, including hypomorphs and neomorphs in addition to complete nulls, can provide novel genetic tools to help elucidate the function of the PCP proteins.
We report the identification of a new N-ethyl-N-nitrosourea (ENU)-induced mutant with craniorachischisis, which we have named chuzhoi (chz). We demonstrate that chuzhoi mutant embryos fail to undergo initiation of neural tube closure, and have characteristics consistent with defective convergent extension. These characteristics include a broadened midline and reduced rate of increase of their length-to-width ratio. In addition, we demonstrate disruption in the orientation of outer hair cells in the inner ear, and defects in heart and lung development in chuzhoi mutants. We demonstrate a genetic interaction between chuzhoi mutants and both Vangl2Lp and Celsr1Crsh mutants, strengthening the hypothesis that chuzhoi is involved in regulating the PCP pathway. We demonstrate that chuzhoi maps to Chromosome 17 and carries a splice site mutation in Ptk7. This mutation results in the insertion of three amino acids into the Ptk7 protein and causes disruption of Ptk7 protein expression in chuzhoi mutants.
The chuzhoi mutant provides an additional genetic resource to help investigate the developmental basis of several congenital abnormalities including neural tube, heart and lung defects and their relationship to disruption of PCP. The chuzhoi mutation differentially affects the expression levels of the two Ptk7 protein isoforms and, while some Ptk7 protein can still be detected at the membrane, chuzhoi mutants demonstrate a significant reduction in membrane localization of Ptk7 protein. This mutant provides a useful tool to allow future studies aimed at understanding the molecular function of Ptk7.